BI-9667

Names

[ Name ]:
BI-9667

Biological Activity

[Description]:

CCR1 antagonist 8 (compound 19n), a third azaindazole series compound, is a CCR1 antagonist clinical candidate, with an IC50 of 1.8 nM in Ca2+ flux assay[1].

[Related Catalog]:

Signaling Pathways >> GPCR/G Protein >> CCR

Signaling Pathways >> Immunology/Inflammation >> CCR

Research Areas >> Inflammation/Immunology

[Target]

CCR1:1.8 nM (IC50, in Ca2+ flux assay)

[References]

[1]. Harcken C, et al. Identification of novel azaindazole CCR1 antagonist clinical candidates. Bioorg Med Chem Lett. 2019 Feb 1;29(3):441-448.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₂H₁₈FN₅O₃S

[ Molecular Weight ]:
451.47

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.